This highly interactive and multidisciplinary workshop is designed to increase the practical knowledge and skills critical to establishing and maintaining a successful program for the care of patients with peritoneal surface malignancies. The first day of the course will focus on a real time HIPEC surgery procedure streamed live to the conference venue, providing unique learning opportunities. National experts will share their knowledge and experience essential to creating a successful and comprehensive peritoneal malignancy program for gastrointestinal and gynecologic malignancies.

1. 5th Annual
MID-ATLANTIC
PERITONEAL
MALIGNANCY
WORKSHOPWITH REAL-TIME HIPEC SURGERY CASE
May 4–5, 2017
INOVA CENTER FOR
PERSONALIZED MEDICINE
CONFERENCE CENTER
FAIRFAX, VA
PROGRAM DIRECTOR:
Lana Bijelic, MD
Medical Director, Surgical Oncology
Inova Health System
www.inova.org/HIPEC

2. 2
This highly interactive and multidisciplinary workshop is
designed to increase the practical knowledge and skills critical
to establishing and maintaining a successful program for
the care of patients with peritoneal surface malignancies.
The first day of the course will focus on a real time HIPEC
surgery procedure streamed live to the conference venue,
providing unique learning opportunities. National experts will
share their knowledge and experience essential to creating
a successful and comprehensive peritoneal malignancy
program for gastrointestinal and gynecologic malignancies.
Conference Target Audience
ʷʷ Surgical Oncologists
ʷʷ General Surgeons
ʷʷ Gynecologic Oncologists
ʷʷ Medical Oncologists
ʷʷ Oncology Nurses/NP’s
Learning Objectives
ʷʷ Analyze and apply appropriate
management options for patients with
appendicular malignancies
ʷʷ Identify criteria used for selection of
patients for cytoreductive surgery as
treatment of peritoneal metastases
from colon cancer
ʷʷ Identify preoperative, intraoperative
and system-based strategies that can
lead to increased rates of complete
cytoredcution for ovarian cancer
ʷʷ Evaluate and implement molecular
profiling approaches and their role
in managing patients with peritoneal
surface malignancies
Accreditation Statement
The Office of Continuing Medical
Education for Inova Health System
designates this live activity for a
maximum of 15.75 AMA PRA Cate-
gory 1 Credit(s)™. Physicians should
claim only the credit commensurate
with the extent of their participation
in the activity.
Physicians may claim up to 15.75
credits in Type 1 CME on the Vir-
ginia Board of Medicine Continued
Competency and Assessment Form
required for renewal of an active
medical license in Virginia.

3. 3
AGENDA
THURSDAY, MAY 4
7:00am – 8:00am Registration and Continental Breakfast
8:00am – 8:15am Opening Remarks and Introduction of Case
Lana Bijelic, MD
8:15am – 8:35am Peritoneal surface malignancies: the role of the surgeon
Speaker TBD
8:35am – 8:50am Discussion
8:50am – 9:15am Operating Room Case Viewing
Paul Sugarbaker, MD, FACS, FRCS
9:20am – 9:40am PMP and appendix cancer: has CRS and HIPEC solved the
problem?
Fabian Johnston, MD, MHS
9:40am – 10:00am Discussion
10:00am – 10:15am Operating Room Case Viewing
Paul Sugarbaker, MD, FACS, FRCS
10:15am – 10:25am Coffee Break and Exhibitors
10:25am – 10:45am Small Groups – Case Studies
10:45am – 11:05am HIPEC for peritoneal metastases from colon cancer in the US
and the world: reality, trends and the role of guidelines
Kiran Turaga, MD, MPH
11:05am – 11:20am Discussion
11:20am – 11:30am Operating Room Case Viewing
Paul Sugabaker, MD, FACS, FRCS
11:30am – 11:50am Peritoneal metastases and the minimally invasive revolution
in colorectal surgery: friend or foe?
Vadim Gushchin, MD, FACS
11:50am – 12:05pm Discussion
12:05pm – 12:30pm Lunch
12:30pm – 1:15pm Lunch Presentation – Tumor Board Discussion
Timothy Cannon, MD
Vadim Gushchin, MD, FACS
Fabian Johnston, MD
Paul Sugarbaker, MD, FACS, FRCS
1:15pm – 1:45pm Keynote lecture
The immune therapy revolution in cancer
care and role in GI cancers
Michael Pishvaian, MD, PhD
1:45pm – 2:00pm Operating Room Case Viewing
Paul Sugarbaker, MD, FACS, FRCS

4. 4
2:00pm – 2:20pm Genomic profiling, liquid biopsies and molecular tumor
boards-can they help patients with peritoneal surface
malignancies?
Timothy Cannon, MD
2:20pm – 2:35pm Discussion
2:35pm – 3:10pm Keynote Lecture
Surgical technique for complete and safe cytoreduction: the
key to success
Paul Sugarbaker, MD, FACS, FRCS
3:10pm – 3:20pm Questions and Answer
3:20pm – 3:30pm Coffee Break and Exhibitors
3:30pm – 3:45pm Operating Room Case Viewing
Paul Sugarbaker, MD, FACS, FRCS
3:45pm – 4:15pm Tumor Board
Kiran Turaga, MD
Richard Hoefer, MD
Michael Pishvaian, MD
Nader Hanna, MD
4:15pm – 4:35pm Selection criteria for surgical treatment of peritoneal
surface malignancy
Nader Hanna, MD
4:35pm – 5:00pm Operating Room Case Viewing
Paul Sugarbaker, MD, FACS, FRCS
5:00pm Adjourn for the day
FRIDAY, MAY 5
7:00am – 8:00am Registration and Continental Breakfast
8:00am – 8:15am Day Two Welcome
Lana Bijelic, MD
8:15am – 8:35am Highlights from PSOGI 2016
Jenny Hong, MD
8:35am – 8:50am Discussion
8:50am – 9:10am Why aren’t most patients with peritoneal malignancy
evaluated at a HIPEC treatment center?
Lana Bijelic, MD
9:10am – 9:25am Discussion
9:25am – 9:45am Setting up a new peritoneal surface malignancy program
Magi Senthil, MD
9:45am – 10:00am Discussion

5. 5
10:00am – 10:15am Coffee Break and Exhibitors
10:15am – 10:50am Keynote Address
Research in surgical sciences
John Niederhuber, MD
10:50am – 11:00am Question and Answer
11:00am – 11:20am Expanded indications for CRS and HIPEC
Mary Beth Hughes, MD, FACS
11:20am – 11:35am Discussion
11:35am – 11:55am The evolution of Ovarian Cancer Treatment
Oliver Zivanovic, MD
11:55am – 12:05am Discussion
12:05am – 12:25pm New developments and current trends in treatment of ovarian
cancer in the US
George L. Maxwell, MD, FACOG, COL (ret)
12:25pm – 12:30pm Discussion
12:30pm – 1:15pm Lunch Case Presentations and Tumor Board
Lana Bijelic, MD
John Elkas, MD
Mary Beth Hughes, MD, FACS
Gaylord Scott Rose, MD
Oliver Zivanovic, MD
Stephanie Wethington MD-moderator
1:15pm – 1:30pm Closing Remarks
1:30pm – 1:45pm Transportation to Inova Fairfax Medical Campus/ASTEC
1:45pm – 4:00pm CRS and HIPEC Simulation
Hands-on demonstration of the OR set up for cytoreductive
surgery and technical aspects of HIPEC administration
Registered participants will have the opportunity to participate
in a hands-on lab in our state of the art simulation facility. The
lab will provide instruction and practice on appropriate patient
preparation and operating room set up for cytoreductive surgery;
set up, administration and take down of heated intraperitoneal
chemotherapy along with appropriate patient monitoring during
HIPEC. We will also address important patient and OR personnel
safety aspects of HIPEC administration and allow participants
many opportunities for direct interaction with faculty.
This lab is primarily of interest to surgeons and their teams who
are just starting a HIPEC program. Nurses, perfusionists and OR
staff are the target audience for this sim lab offering.

6. 6
Lana Bijelic, MD
Medical Director, Surgical Oncology
Inova Health System
Timothy Cannon, MD
GI Medical Oncology
Clinical Director, Molecular Tumor Board
Inova Health System
John Elkas, MD
Gynecologic Oncology,
Obstetrics and Gynecology
Inova Health System
Mid-Atlantic Gynecology Oncology
and Pelvic Surgery Associates
Vadim Gushchin, MD, FACS
Director, Gastrointestinal Oncology
Mercy Medical Center
Nader Hanna, MD
Professor of Surgery
University of Maryland Medical Center
Richard Hofer, DO
Sentara Surgery Specialists
Surgical Oncology
Jenny Hong, MD, MPH
Surgical Oncology
MedStar Washington Hospital Center
Mary Beth Hughes, MD, FACS
Surgical Oncology
Eastern Virginia Medical School
Fabian Johnston, MD, MHS
Co-Director of the Peritoneal
Surface Malignancy Program
Assistant Professor of Surgery,
Johns Hopkins Medicine
G. Larry Maxwell, MD, FACOG, COL (ret)
Inova Health System, Chair of the
Department of Obstetrics and Gynecology
Gynecologic Cancer Translational
Research Center, Co-Director of the
Department of Defense (DOD)
Virginia Commonwealth University
School of Medicine and at Uniformed
Services University School of Medicine,
Professor in the Department of
Obstetrics and Gynecology
Walter Reed National Military Medical
Center, Division of Gynecologic
Oncology, Research Director of
Fellowship of Gynecologic Oncology
John Niederhuber, MD
Executive Vice President and CEO
Inova Translational Medicine Institute
Adjunct Professor of
Oncology and Surgery
Johns Hopkins University
School of Medicine
Deputy Director, Johns Hopkins
Clinical Research Network
Michael Pishvaian, MD, PhD
Medical Oncology
Director, Phase I Clinical Program
Co-Director of the Ruesch Center
for Pancreatic Cancer Program
MedStar Health
Gaylord Scott Rose, MD
Gynecologic Oncology,
Obstetrics and Gynecology
Inova Health System
Mid-Atlantic Gynecology Oncology
and Pelvic Surgery Associates
Magi Senthil, MD
Chief, Surgical Oncology Division at
Loma Linda University Medical Center
COURSE FACULTY

7. 7
Paul H. Sugarbaker, MD, FACS, FRCS
Medical Director, Center for
Gastrointestinal Malignancies
Chief, Program in Peritoneal
Surface Oncology
MedStar Washington Hospital Center
Kiran Turaga, MD, MPH
Associate Professor of Surgery
Vice Chief, Section of General Surgery and
Surgical Oncology (Strategy and Finance)
Director, Surgical GI Cancer Program
Director, Regional Therapeutics Program
Stephanie Wethington, MD, MS, M.Sc.
Gynecologic Oncology, Assistant
Professor of Gynecology and Obstetrics
Johns Hopkins Medicine
Oliver Zivanovic, MD
Director, Innovative Surgical
Technology, Gynecology Service,
Department of Surgery
Memorial Sloan Kettering Cancer Center
Registration
Register today online by visiting
www.inova.org/HIPEC
Registration Fees:
Inova/IMG Physician: $199.00
Physician: $249.00
Nurse, Fellow and Resident: $149.00
Cancellation Policy
Registration cancellation is only accepted
prior to April 20, 2017 via email to Marchelle
Albertson, marchelle.albertson@inova.org. The
registration fee is non-refundable after the
cancellation date.
Course Syllabus
In maintaining Inova Green standards, the
course syllabus will be available online this
year with log-in information given at the
conference during check-in. Please be sure to
bring your laptop or tablet for complimentary
Wi-Fi service to access the syllabus.
ADA Compliance
Inova CME complies with the Americans with
Disabilities Act. If you require assisted services
facilities or dietary considerations (outside of
vegetarian) to support your participation in
this CME program, please contact Marchelle
Albertson, marchelle.albertson@inova.org at
least 14 days prior to the conference date.
On-Site Parking
Parking is complimentary at the Inova Center
for Personalized Health (ICPH).
Hotel Accommodations (accessible to
Inova via taxi – walking not recommended)
Fairview Park Marriott
3111 Fairview Park Drive, Falls Church, VA 22042
703-849-9400
Hyatt House Merrifield
8296 Glass Alley, Fairfax, VA 22031
571-327-2277
For More Information:
Marchelle Albertson, Program Manager
marchelle.albertson@inova.org or
703-204-6348
www.inova.org/HIPEC
CONFERENCE DETAILS

8. 5th Annual
MID-ATLANTIC
PERITONEAL
MALIGNANCY
WORKSHOPWITH REAL-TIME HIPEC SURGERY CASE
May 4–5, 2017
www.inova.org/HIPEC